Researchers are exploring various approaches to improve the diagnosis of colorectal cancer, including the development of new tests and analysis of the gut microbiome. Several companies have introduced or received certification for diagnostic tests, such as companion diagnostics and minimal residual disease tests, which may aid in earlier diagnosis or guide treatment. The effectiveness of these tests is being evaluated in studies and trials, with some showing promise for improving colorectal cancer screening and treatment.